CTA
BSX icon

Colonial Trust Advisors’s Boston Scientific BSX Stock Holding History

Colonial Trust Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25
Closed -$1.71K – 797
2024
Q1 		$1.71K Sell
25
-12
-32% -$772 ﹤0.01% 815
2023
Q4 		$2.14K Hold
37
– – ﹤0.01% 706
2023
Q3 		$1.95K Hold
37
– – ﹤0.01% 722
2023
Q2 		$2K Hold
37
– – ﹤0.01% 744
2023
Q1 		$1.85K Buy
37
+8
+28% +$377 ﹤0.01% 735
2022
Q4 		$1.34K Buy
+29
New +$1.26K ﹤0.01% 771

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Colonial Trust Advisors's BSX Position: Q2 2024 in Review

Colonial Trust Advisors sold out of Boston Scientific (BSX) in Q2 2024, closing a stake of 25 shares — an estimated $1.71K sold.

Colonial Trust Advisors first reported a position in BSX in Q4 2022 and held it in 6 quarters. The position peaked at $2.14K in Q4 2023. 1,317 funds tracked by Wall St. Rank hold BSX as of Q2 2024.

  • Colonial Trust Advisors reported no remaining Boston Scientific position as of Q2 2024 after selling out during the quarter.
  • Colonial Trust Advisors sold 25 Boston Scientific shares in Q2 2024, an estimated $1.71K.
  • Colonial Trust Advisors first reported a position in Boston Scientific in Q4 2022 and held it in 6 quarters.
  • Colonial Trust Advisors's Boston Scientific position peaked at $2.14K in Q4 2023.
  • 1,317 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2024.

Based on Colonial Trust Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.